154 related articles for article (PubMed ID: 11322651)
21. Combination therapy with thymosin alpha1 and dexamethasone helps mice survive sepsis.
Xiang XS; Li N; Zhao YZ; Li QR; Li JS
Inflammation; 2014 Apr; 37(2):402-16. PubMed ID: 24122349
[TBL] [Abstract][Full Text] [Related]
22. Thymosin alpha1 inhibits mammary carcinogenesis in Fisher rats.
Moody TW; Tuthill C; Badamchian M; Goldstein AL
Peptides; 2002 May; 23(5):1011-4. PubMed ID: 12084534
[TBL] [Abstract][Full Text] [Related]
23. Immunoregulation in aging.
Doria G; Adorini L; Sabbadini E; Mancini C; Frasca D
Ann N Y Acad Sci; 1988; 521():182-8. PubMed ID: 2897816
[No Abstract] [Full Text] [Related]
24. Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice.
Mastino A; Favalli C; Grelli S; Rasi G; Pica F; Goldstein AL; Garaci E
Int J Cancer; 1992 Feb; 50(3):493-9. PubMed ID: 1735618
[TBL] [Abstract][Full Text] [Related]
25. Generation of a novel long-acting thymosin alpha1-Fc fusion protein and its efficacy for the inhibition of breast cancer in vivo.
Shen X; Li Q; Wang F; Bao J; Dai M; Zheng H; Lao X
Biomed Pharmacother; 2018 Dec; 108():610-617. PubMed ID: 30243095
[TBL] [Abstract][Full Text] [Related]
26. Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application.
Tao N; Xu X; Ying Y; Hu S; Sun Q; Lv G; Gao J
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110771
[TBL] [Abstract][Full Text] [Related]
27. IRX-2 and thymosin alpha1 (Zadaxin) increase T lymphocytes in T lymphocytopenic mice and humans.
Hadden JW; Verastegui E; Hadden E
Ann N Y Acad Sci; 2007 Sep; 1112():245-55. PubMed ID: 17600288
[TBL] [Abstract][Full Text] [Related]
28. Thymosin α1 promotes the activation of myeloid-derived suppressor cells in a Lewis lung cancer model by upregulating Arginase 1.
Yuan C; Zheng Y; Zhang B; Shao L; Liu Y; Tian T; Gu X; Li X; Fan K
Biochem Biophys Res Commun; 2015 Aug; 464(1):249-55. PubMed ID: 26111447
[TBL] [Abstract][Full Text] [Related]
29. Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma.
Li Y; McGowan P; Hellström I; Hellström KE; Chen L
J Immunol; 1994 Jul; 153(1):421-8. PubMed ID: 7515929
[TBL] [Abstract][Full Text] [Related]
30. Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells.
Liu Y; Pan Y; Hu Z; Wu M; Wang C; Feng Z; Mao C; Tan Y; Liu Y; Chen L; Li M; Wang G; Yuan Z; Diao B; Wu Y; Chen Y
Clin Infect Dis; 2020 Nov; 71(16):2150-2157. PubMed ID: 32442287
[TBL] [Abstract][Full Text] [Related]
31. Reconstitution of T cell functions in aging mice by thymosin alpha 1.
Frasca D; Adorini L; Mancini C; Doria G
Immunopharmacology; 1986 Jun; 11(3):155-63. PubMed ID: 2942521
[TBL] [Abstract][Full Text] [Related]
32. Thymosin alpha one restores murine T-cell-mediated responses inhibited by in vivo cocaine administration.
Di Francesco P; Pica F; Marini S; Favalli C; Garaci E
Int J Immunopharmacol; 1992 Jan; 14(1):1-9. PubMed ID: 1582729
[TBL] [Abstract][Full Text] [Related]
33. High doses of thymosin alpha 1 enhance the anti-tumor efficacy of combination chemo-immunotherapy for murine B16 melanoma.
Pica F; Fraschetti M; Matteucci C; Tuthill C; Rasi G
Anticancer Res; 1998; 18(5A):3571-8. PubMed ID: 9858941
[TBL] [Abstract][Full Text] [Related]
34. Zoledronic acid and thymosin α1 elicit antitumor immunity against prostate cancer by enhancing tumor inflammation and cytotoxic T cells.
Wang S; Huang M; Chen M; Sun Z; Jiao Y; Ye G; Pan J; Ye W; Zhao J; Zhang D
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37295817
[TBL] [Abstract][Full Text] [Related]
35. Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance.
Romani L; Bistoni F; Perruccio K; Montagnoli C; Gaziano R; Bozza S; Bonifazi P; Bistoni G; Rasi G; Velardi A; Fallarino F; Garaci E; Puccetti P
Blood; 2006 Oct; 108(7):2265-74. PubMed ID: 16741252
[TBL] [Abstract][Full Text] [Related]
36. Immunopharmacology of thymosin alpha1 and cytokine synergy.
Naylor PH; Quadrini K; Garaci E; Rasi G; Hadden JW
Ann N Y Acad Sci; 2007 Sep; 1112():235-44. PubMed ID: 17567942
[TBL] [Abstract][Full Text] [Related]
37. Thymosin alpha-1 modulates excitatory synaptic transmission in cultured hippocampal neurons in rats.
Yang S; Liu ZW; Zhou WX; Zhang YX
Neurosci Lett; 2003 Oct; 350(2):81-4. PubMed ID: 12972158
[TBL] [Abstract][Full Text] [Related]
38. Low zone tolerance to contact allergens in mice: a functional role for CD8+ T helper type 2 cells.
Steinbrink K; Sorg C; Macher E
J Exp Med; 1996 Mar; 183(3):759-68. PubMed ID: 8642280
[TBL] [Abstract][Full Text] [Related]
39. Clonal growth inhibition as a bioassay for thymosin alpha1: inactivation of Talpha1 by trifluroacetic acid.
Bianco-Batlles D; Naylor CW; Moshier JA; Dosescu J; Naylor PH
Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):157-60. PubMed ID: 11292250
[TBL] [Abstract][Full Text] [Related]
40. Thymosin alpha1. SciClone Pharmaceuticals.
Billich A
Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
